Groww IPO Day 2: Fully Subscribed (1.47x); Retail 4.65x, GMP 11–15%; Nithin Kamath Says 20% of Applications Came via Zerodha — What Top Brokerages Recommend
6 November 2025
4 mins read

Groww IPO Day 2: Fully Subscribed (1.47x); Retail 4.65x, GMP 11–15%; Nithin Kamath Says 20% of Applications Came via Zerodha — What Top Brokerages Recommend

Updated: 6 Nov 2025, 4:45 pm IST


What happened today (6 Nov)

  • The ₹6,632.3‑crore Groww IPO was fully subscribed on Day 2, with overall bids at 1.47x by mid‑afternoon; retail participation led the charge at 4.65x, NIIs at 1.88x, and QIBs at 0.20x (as per NSE data tracked during the session). 1
  • Grey market premium (GMP) cooled through the day, fluctuating in the ~11–15% range versus the issue price. 1
  • Zerodha’s Nithin Kamath congratulated Groww and said about 20% of Groww IPO applications are coming from Zerodha customers, underscoring crossover retail interest. 2
  • A broad “Subscribe” chorus from top brokerages continued today, with some caution on valuation. 3

Subscription status: the scoreboard at a glance

  • Overall: 1.47x (147%)
  • Retail: 4.65x (465%)
  • NII/HNI: 1.88x (188%)
  • QIB: 0.20x (20%)

Snapshot reflects live tallies captured around 3:24 pm IST on Day 2. Final end‑of‑day figures can vary once the exchanges publish consolidated data. 1

A separate mid‑day cut from global wires also flagged the issue as “fully booked” by late morning today, driven by retail demand. 4


Price band, lot size, structure, and key dates

  • Price band: ₹95–₹100 per share
  • Lot size:150 shares (₹15,000 for one lot at the upper band)
  • Issue size:₹6,632.30 crore, comprising a ₹1,060 crore fresh issue and an OFS of ₹5,572.30 crore by existing investors
  • Timeline: Closes Nov 7 (Fri); allotment expected Nov 10 (Mon); listing likely Nov 12 (Wed) on BSE & NSE
  • Anchor round:₹2,985 crore allocated to anchors on Nov 3 (≈29.84 crore shares at ₹100)
    These terms and dates were reiterated across exchange‑tracked updates and publisher reports today. 1

Who’s going public?

The issuer is Billionbrains Garage Ventures Ltd, the parent of Groww, a mobile‑first investing platform spanning equities, F&O, mutual funds, and bonds. Recent coverage highlights Groww’s push beyond broking into wealth, commodities, and margin products—strategies expected to broaden revenue mix over time. 5


Day‑2 talking points the market cared about

1) Retail momentum stayed strong

Retail investors continued to power the book, pushing the retail tranche near 5x by mid‑afternoon. That enthusiasm fits the pattern of retail‑led tech/fin‑serv listings through 2024–25 and often compensates for slower early bids from institutions. 1

2) GMP cooled but remained positive

Unofficial grey‑market indicators trended ~₹11–₹15 above the upper band during the session, implying a ~11–15% indicative pop versus the issue price—but GMP is not an official data point and can change quickly into listing. 1

3) Cross‑platform flow is real

Nithin Kamath (Zerodha) publicly applauded Groww’s IPO and noted that ~20% of Groww IPO applications are flowing from Zerodha customers—an unusual, friendly signal from a rival and a proof‑point of India’s deepening retail participation. 2


What top brokerages said on Day 2

An ET Markets round‑up today captured a broad “Subscribe” consensus with a few neutral/valuation‑focused takes:

  • SBI Securities: Subscribe, citing leadership with ~12.6 million active NSE clients and strength in MF AUM/SIPs. 3
  • Anand Rathi: Subscribe – Long Term; “fully priced” but backed by strong engagement and expansion into MTF/wealth/bonds. 3
  • Kunvarji Wealth: Subscribe (M–L term); mobile‑first, scalable platform; in‑house tech a differentiator. 3
  • Religare (WealthVia): Subscribe; calls Groww a “fintech infrastructure company in the making”; notes NBFC arm Groww Creditserv. 3
  • SMIFS: Subscribe for long term; integrated digital ecosystem and rapid client growth. 3
  • Master Capital Services (MasterTrust): Subscribe (LT); benefits from fintech penetration and largest user base by active NSE clients. 3
  • Choice & Asit C. Mehta: Subscribe for long term; strong brand, retention, engagement; valuation “fully priced” vs peers. 3
  • Bajaj Broking: Neutral (non‑rated); cites ~29.9x FY25 earnings valuation and strong retail presence. 3
  • Angel One:Neutral; flags post‑issue P/E ~40.8x at the upper band as steep. 1

How the numbers stack up

  • Scale & engagement: Brokerages point to Groww’s ~12.6 million active NSE clients and leadership in net new demat additions and active SIPs (June 2025), plus 100M+ cumulative app downloads—all inline with a retail‑first franchise. 3
  • Valuation lens: Street notes range from ~29.9x FY25 (Bajaj Broking perspective) to ~40.79x post‑issue P/E (Angel One) at ₹100, reinforcing the “quality + premium” debate. 3
  • Use of proceeds / structure: A majority OFS by existing investors with a ₹1,060 crore primary component; anchors already absorbed ₹2,985 crore at ₹100. 1

GMP watch: why it matters—and why it doesn’t

GMPs offer a sentiment snapshot, not a forecast. Today’s 11–15% range signals healthy interest but has already softened from earlier days (e.g., ~14.75% yesterday). Liquidity, day‑3 QIB demand, and market tone can all shift this quickly before listing. 1


Key dates you need to know

  • Day 3 (Final day to bid):Fri, Nov 7
  • Allotment:Mon, Nov 10
  • Listing:Wed, Nov 12
  • Lot size:150 shares (₹15,000 at ₹100)
    Keep an eye on QIB bids tomorrow; institutional demand typically firms up on the final day and often sets the tone for listing sentiment. 2

FAQ (Investor quick‑read)

What is the Groww IPO price band and issue size?
₹95–₹100 per share; ₹6,632.30 crore (₹1,060 crore fresh + ₹5,572.30 crore OFS). 1

How much was subscribed on Day 2?
Overall 1.47x by ~3:24 pm; Retail 4.65x, NII 1.88x, QIB 0.20x (intra‑day snapshot). 1

What is the lot size and minimum investment?
150 shares; ₹15,000 at the upper band for one lot. 1

What are brokerages recommending?
Mostly “Subscribe (long term)”, with valuation caution from some houses (e.g., Angel One neutral). 3

When will Groww list?
Tentatively Nov 12, 2025, subject to timelines. 2


Editorial note

This article summarizes today’s developments (6 Nov) around Groww’s IPO, combining exchange‑tracked subscription snapshots with publisher reports. Nothing here is investment advice. Please consult a SEBI‑registered advisor before investing.


Sources

  • Subscription, GMP & structure: Moneycontrol live updates and story on Day 2. 1
  • Rival reaction & anchors; timeline: NDTV (Kamath’s post; allotment/listing schedule; anchor allocation details). 2
  • Brokerage verdicts & metrics (active clients/SIP share): ET Markets Day‑2 recap of top‑10 broker views. 3
  • Mid‑day confirmation of full subscription: Reuters update. 4

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Investors Beware: 7 Stocks to Avoid on October 22, 2025 Amid Alarming Warnings
Previous Story

Michael Burry’s $1.1 Billion AI ‘Short’ Jolts Global Markets: Nvidia, Palantir Lead Tech Slide — What to Watch Today (Nov. 6, 2025)

Duolingo (DUOL) Plunges After Soft Q4 Bookings Outlook Despite Q3 Beat; Daily Users Top 50 Million — What to Know Today (Nov. 6, 2025)
Next Story

Duolingo (DUOL) Plunges After Soft Q4 Bookings Outlook Despite Q3 Beat; Daily Users Top 50 Million — What to Know Today (Nov. 6, 2025)

Go toTop